Oleuropein and HT emerge as transformative agents capable of degrading EGFR in several cancer cell lines, as well as quercetin, apigenin, EGCG, and resveratrol
Ingredients: Water, Butylene Glycol, Niacinamide, Panthenol, Tranexamic Acid, 1,2-Hexanediol, Neopentyl Glycol Dicaprate, Caprylic/Capric Triglyceride, Sorbitol, Vaccinium Vitis-Idaea Fruit Extract, Chondrus Crispus Extract, Butyrospermum Parkii Butter, Saccharum Officinarum Extract, Alpha-Arbutin, Bifida Ferment Lysate, Sodium Hyaluronate, Melia Azadirachta Flower Extract, Ocimum Sanctum Leat Extract, Melia Azadirachta Leaf Extract, Curcuma Longa Root Extract, Corallina Officinalis Extract, Tremella Fuciformis Extract, Pentylene Glycol, Glycerin, 3-O-Ethyl Ascorbic Acid, Bisabolol, Tromethamine, Ethylhexylglycerin, Adenosine, Hydrogenated Lecithin, Allantoin, Glutathione, Ceramide NP, Beta-Glucan, Dipotassium Glycyrrhizate, Tocopherol, Ascorbic Acid, Ascorbyl Glucoside, Tocopheryl Acetate, Hydroxypropyl Cyclodextrin, Ubiquinone, Thioctic Acid, Potassium Hydroxide, Behenyl Alcohol, Carbomer, Xanthan Gum, Disodium EDTA
the "L" prefix indicates the biologically active L-isomer (the form the body recognizes)
Alabdali, A., Al-Ayadhi, L., & El-Ansary, A
BPC-157 has been examined in experimental models involving the gastrointestinal tract, tendons, ligaments, muscle, bone, wounds, blood vessels and inflammatory signalling
Maintenance doses either oral or periodic IV are usually recommended to sustain results
